Clinical Trial Update: The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the effect of SHR20004 (Noiiglutide) on body weight in obese subjects without diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SHR20004 (Noiiglutide) (Noiiglutide)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Obesity | Phase 2 | Status: UNKNOWN